ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 37 filers reported holding ATYR PHARMA INC in Q4 2022. The put-call ratio across all filers is 12.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,988 | -92.5% | 10,947 | -92.2% | 0.00% | -100.0% |
| Q4 2022 | $307,247 | -41.7% | 140,296 | -20.2% | 0.00% | 0.0% |
| Q3 2022 | $527,000 | +17.1% | 175,910 | +10.4% | 0.00% | 0.0% |
| Q2 2022 | $450,000 | -58.6% | 159,407 | -21.5% | 0.00% | -50.0% |
| Q1 2022 | $1,086,000 | -42.0% | 203,007 | -18.9% | 0.00% | -33.3% |
| Q4 2021 | $1,871,000 | +379.7% | 250,396 | +482.2% | 0.00% | +50.0% |
| Q3 2021 | $390,000 | – | 43,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
| Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
| VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
| FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
| Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
| Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
| Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
| CITIGROUP INC | 428,460 | $938,327 | 0.00% |
| PFS Partners, LLC | 406 | $890 | 0.00% |